Skip to main content
. 2022 Nov 9;14(1):68–72. doi: 10.1111/1759-7714.14715

TABLE 3.

Chi‐squared analysis and Fisher's exact test for grade of increased creatinine

Grade 1 Grade 2 p Grade 1 Grade 2 p
Age (years) 0.81 Type of endocrine therapy 0.44
<60 82 38 AI 65 28
≥60 48 24 Fulvestrant 59 31
Weight (kg) TAM 3 3
<68.5 91 37 0.16 NA 3 0
≥68.5 39 25 Start dose of abemaciclib (mg/bid) 0.33
Menopausal status a 0.00 150 115 53
Premenopausal 56 13 100 12 9
Postmenopausal 74 49 50 3 0
Bone metastases status 0.18 Dose modifications 0.18
Yes 53 19 Yes 24 6
No 77 43 No 100 50
Osteoclast inhibitors 0.28 NA 6 6
Bisphosphonate 42 18
Denosumab 6 0
Bisphosphonate/denosumab 2 1
None 77 43
NA 3 0

Abbreviations: AI, aromatase inhibitors; bid, bis in die; NA, not access; TAM, tamoxifen.

a

The difference between groups is significant.